Effect of sirolimus on coagulopathy of slow-flow vascular malformations.

Joana M MackBethany VerkampGresham T RichterRichard NicholasKelly StewartShelley E Crary

Published in: Pediatric blood & cancer (2019)

This study suggests that sirolimus improves coagulopathy in slow-flow vascular malformations, as evidenced by reduced D-dimer levels. Improvement in LIC symptoms also correlates with sirolimus-corrected coagulopathy.

Keyphrases

physical activity